发明名称 PYRAZOLO[3,4-G]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE
摘要 This invention relates to pyrazolo¢3,4-g!quinoxaline compounds exhibiting protein tyrosine kinase inhibition activity. More specifically, compounds of this invention are novel as selective inhibitors of the PDGF-R protein tyrosine kinase and can be applied as potential therapeutic agents for various disease states which are characterized by uncontrolled cellular proliferation. Further, the present invention provides pharmaceutical compositions and a method for treating such disorders comprising the administration to a patient of a PDGF receptor inhibiting effective amount of a pyrazolo¢3,4-g!quinoxaline compound exhibiting protein tyrosine kinase inhibition activity. Processes for the preparation of pyrazolo¢3,4-g!quinoxaline compounds.
申请公布号 CA2198005(A1) 申请公布日期 1996.03.14
申请号 CA19952198005 申请日期 1995.09.06
申请人 RHONE-POULENC RORER PHARMACEUTICALS INC. 发明人 MYERS, MICHAEL R.;PERSONS, PAUL E.;LY, CUONG Q.;SPADA, ALFRED P.
分类号 A61K31/495;A61P9/10;A61P13/02;A61P15/00;A61P29/00;A61P35/00;A61P35/02;C07D487/04;(IPC1-7):C07D487/04 主分类号 A61K31/495
代理机构 代理人
主权项
地址